Zhejiang Qianjiang Biochemical Co., Ltd (SHA:600796)
China · Delayed Price · Currency is CNY 5.25
+0.06 (1.16%)
Sep 7, 2026, 1:14 PM CST
SHA:600796 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Revenue | 1,639 | 1,682 | 1,765 | 2,031 | 2,004 | 2,020 |
Other Revenue | 8.03 | 11.83 | 3.58 | 3.74 | 4.46 | 11.06 |
| 1,647 | 1,694 | 1,768 | 2,034 | 2,009 | 2,031 | |
Revenue Growth | -2.25% | -4.22% | -13.08% | 1.27% | -1.08% | 7.55% |
Cost of Revenue | 1,227 | 1,275 | 1,364 | 1,556 | 1,569 | 1,564 |
Gross Profit | 420.09 | 418.77 | 404.83 | 478.75 | 439.57 | 466.59 |
Selling, General & Admin | 128.18 | 136.9 | 159.79 | 166.45 | 150.15 | 136.98 |
Research & Development | 25.57 | 27.85 | 29.83 | 28.41 | 31.45 | 32.03 |
Other Operating Expenses | 15.43 | 16.85 | 3.76 | -0.49 | 6.83 | 3.17 |
Operating Expenses | 201.2 | 220.67 | 234.78 | 213.37 | 190.37 | 175.12 |
Operating Income | 218.89 | 198.11 | 170.06 | 265.38 | 249.2 | 291.48 |
Interest Expense | -27.18 | -54.99 | -78.71 | -89.12 | -92.43 | -75.36 |
Interest & Investment Income | 8.63 | 57.73 | 75.36 | 60.54 | 70.34 | 5.32 |
Currency Exchange Gain (Loss) | -0.25 | -0.13 | 1.05 | 0.66 | 1.72 | 1.7 |
Other Non Operating Income (Expenses) | -47.63 | -10.78 | -7.4 | -10.2 | -15.19 | -18.54 |
EBT Excluding Unusual Items | 169.8 | 189.94 | 160.35 | 227.26 | 213.63 | 204.6 |
Gain (Loss) on Sale of Assets | 1.75 | 3.83 | 0.89 | 9.1 | 9.52 | 0.51 |
Asset Writedown | -6.13 | - | - | -9.26 | -3.01 | - |
Other Unusual Items | 5.07 | 7.63 | 13.09 | 1.73 | 20.12 | 4.62 |
Pretax Income | 170.5 | 201.4 | 174.33 | 228.84 | 240.27 | 209.73 |
Income Tax Expense | 36.78 | 45.76 | 48.98 | 45.94 | 50.17 | 46.98 |
Earnings From Continuing Operations | 133.71 | 155.65 | 125.35 | 182.9 | 190.1 | 162.75 |
Minority Interest in Earnings | 3.3 | 10.72 | 34.65 | 27.79 | 15.95 | -14.81 |
Net Income | 137.01 | 166.36 | 160 | 210.69 | 206.05 | 147.94 |
Net Income to Common | 137.01 | 166.36 | 160 | 210.69 | 206.05 | 147.94 |
Net Income Growth | -25.89% | 3.98% | -24.06% | 2.25% | 39.28% | 53.89% |
Shares Outstanding (Basic) | 861 | 876 | 889 | 878 | 859 | 672 |
Shares Outstanding (Diluted) | 861 | 876 | 889 | 878 | 859 | 672 |
Shares Change | -1.93% | -1.50% | 1.26% | 2.25% | 27.67% | 4.92% |
EPS (Basic) | 0.16 | 0.19 | 0.18 | 0.24 | 0.24 | 0.22 |
EPS (Diluted) | 0.16 | 0.19 | 0.18 | 0.24 | 0.24 | 0.22 |
EPS Growth | -24.43% | 5.56% | -25.00% | 0% | 9.09% | 46.67% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 282.62 | 178.82 | -446.07 | 117.73 | 34.38 | -199.62 |
Free Cash Flow Per Share | 0.33 | 0.20 | -0.50 | 0.13 | 0.04 | -0.30 |
Dividend Per Share | 0.031 | 0.031 | 0.031 | 0.031 | 0.102 | 0.100 |
Dividend Growth | 0% | 0% | 0% | -69.61% | 2.00% | - |
Gross Margin | 25.50% | 24.73% | 22.89% | 23.53% | 21.88% | 22.98% |
Operating Margin | 13.29% | 11.70% | 9.62% | 13.05% | 12.40% | 14.35% |
Profit Margin | 8.32% | 9.82% | 9.05% | 10.36% | 10.26% | 7.28% |
Free Cash Flow Margin | 17.16% | 10.56% | -25.22% | 5.79% | 1.71% | -9.83% |
EBITDA | 386.92 | 389.34 | 404.47 | 490.69 | 484.82 | 473.82 |
EBITDA Margin | 23.49% | 22.99% | 22.87% | 24.12% | 24.13% | 23.33% |
D&A For EBITDA | 168.03 | 191.23 | 234.42 | 225.31 | 235.62 | 182.35 |
EBIT | 218.89 | 198.11 | 170.06 | 265.38 | 249.2 | 291.48 |
EBIT Margin | 13.29% | 11.70% | 9.62% | 13.05% | 12.40% | 14.35% |
Effective Tax Rate | 21.57% | 22.72% | 28.09% | 20.08% | 20.88% | 22.40% |
Revenue as Reported | 914.11 | 1,694 | 1,768 | 2,034 | 2,009 | 2,031 |